0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pets NSAIDs Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-38H13181
Home | Market Reports | Pets & Animals
Global Pets NSAIDs Market Research Report 2023
BUY CHAPTERS

Global Pets NSAIDs Market Research Report 2025

Code: QYRE-Auto-38H13181
Report
January 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pets NSAIDs Market Size

The global market for Pets NSAIDs was valued at US$ 470 million in the year 2024 and is projected to reach a revised size of US$ 698 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Pets NSAIDs Market

Pets NSAIDs Market

Veterinary nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to control fever, pain, and other signs of inflammation in animals. Inflammation is the body"s response to irritation or injury and results in redness, warmth, swelling, and pain in the inflamed area.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 43%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pets NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets NSAIDs.
The Pets NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pets NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pets NSAIDs Market Report

Report Metric Details
Report Name Pets NSAIDs Market
Accounted market size in year US$ 470 million
Forecasted market size in 2031 US$ 698 million
CAGR 5.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection Type
  • Oral Type
  • Others
Segment by Application
  • Pet Hospital
  • Pet Shop
  • Household Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Bayer, JandJ, GSK, Septodont, Roche, PerioChip, Mobic, Rimadyl, Vetprofen, Novox
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pets NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pets NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pets NSAIDs Market growing?

Ans: The Pets NSAIDs Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Pets NSAIDs Market size in 2031?

Ans: The Pets NSAIDs Market size in 2031 will be US$ 698 million.

Who are the main players in the Pets NSAIDs Market report?

Ans: The main players in the Pets NSAIDs Market are Merck, Bayer, JandJ, GSK, Septodont, Roche, PerioChip, Mobic, Rimadyl, Vetprofen, Novox

What are the Application segmentation covered in the Pets NSAIDs Market report?

Ans: The Applications covered in the Pets NSAIDs Market report are Pet Hospital, Pet Shop, Household Use

What are the Type segmentation covered in the Pets NSAIDs Market report?

Ans: The Types covered in the Pets NSAIDs Market report are Injection Type, Oral Type, Others

Recommended Reports

Pet Health & Care

Veterinary Equipment

Animal Disease Control

1 Pets NSAIDs Market Overview
1.1 Product Definition
1.2 Pets NSAIDs by Type
1.2.1 Global Pets NSAIDs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection Type
1.2.3 Oral Type
1.2.4 Others
1.3 Pets NSAIDs by Application
1.3.1 Global Pets NSAIDs Market Value by Application (2024 VS 2031)
1.3.2 Pet Hospital
1.3.3 Pet Shop
1.3.4 Household Use
1.4 Global Pets NSAIDs Market Size Estimates and Forecasts
1.4.1 Global Pets NSAIDs Revenue 2020-2031
1.4.2 Global Pets NSAIDs Sales 2020-2031
1.4.3 Global Pets NSAIDs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pets NSAIDs Market Competition by Manufacturers
2.1 Global Pets NSAIDs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pets NSAIDs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pets NSAIDs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pets NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pets NSAIDs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pets NSAIDs, Product Type & Application
2.7 Global Key Manufacturers of Pets NSAIDs, Date of Enter into This Industry
2.8 Global Pets NSAIDs Market Competitive Situation and Trends
2.8.1 Global Pets NSAIDs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pets NSAIDs Players Market Share by Revenue
2.8.3 Global Pets NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pets NSAIDs Market Scenario by Region
3.1 Global Pets NSAIDs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pets NSAIDs Sales by Region: 2020-2031
3.2.1 Global Pets NSAIDs Sales by Region: 2020-2025
3.2.2 Global Pets NSAIDs Sales by Region: 2026-2031
3.3 Global Pets NSAIDs Revenue by Region: 2020-2031
3.3.1 Global Pets NSAIDs Revenue by Region: 2020-2025
3.3.2 Global Pets NSAIDs Revenue by Region: 2026-2031
3.4 North America Pets NSAIDs Market Facts & Figures by Country
3.4.1 North America Pets NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pets NSAIDs Sales by Country (2020-2031)
3.4.3 North America Pets NSAIDs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pets NSAIDs Market Facts & Figures by Country
3.5.1 Europe Pets NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pets NSAIDs Sales by Country (2020-2031)
3.5.3 Europe Pets NSAIDs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pets NSAIDs Market Facts & Figures by Region
3.6.1 Asia Pacific Pets NSAIDs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pets NSAIDs Sales by Region (2020-2031)
3.6.3 Asia Pacific Pets NSAIDs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pets NSAIDs Market Facts & Figures by Country
3.7.1 Latin America Pets NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pets NSAIDs Sales by Country (2020-2031)
3.7.3 Latin America Pets NSAIDs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pets NSAIDs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pets NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pets NSAIDs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pets NSAIDs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pets NSAIDs Sales by Type (2020-2031)
4.1.1 Global Pets NSAIDs Sales by Type (2020-2025)
4.1.2 Global Pets NSAIDs Sales by Type (2026-2031)
4.1.3 Global Pets NSAIDs Sales Market Share by Type (2020-2031)
4.2 Global Pets NSAIDs Revenue by Type (2020-2031)
4.2.1 Global Pets NSAIDs Revenue by Type (2020-2025)
4.2.2 Global Pets NSAIDs Revenue by Type (2026-2031)
4.2.3 Global Pets NSAIDs Revenue Market Share by Type (2020-2031)
4.3 Global Pets NSAIDs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pets NSAIDs Sales by Application (2020-2031)
5.1.1 Global Pets NSAIDs Sales by Application (2020-2025)
5.1.2 Global Pets NSAIDs Sales by Application (2026-2031)
5.1.3 Global Pets NSAIDs Sales Market Share by Application (2020-2031)
5.2 Global Pets NSAIDs Revenue by Application (2020-2031)
5.2.1 Global Pets NSAIDs Revenue by Application (2020-2025)
5.2.2 Global Pets NSAIDs Revenue by Application (2026-2031)
5.2.3 Global Pets NSAIDs Revenue Market Share by Application (2020-2031)
5.3 Global Pets NSAIDs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Pets NSAIDs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Pets NSAIDs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 JandJ
6.3.1 JandJ Company Information
6.3.2 JandJ Description and Business Overview
6.3.3 JandJ Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 JandJ Pets NSAIDs Product Portfolio
6.3.5 JandJ Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK Pets NSAIDs Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Septodont
6.5.1 Septodont Company Information
6.5.2 Septodont Description and Business Overview
6.5.3 Septodont Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Septodont Pets NSAIDs Product Portfolio
6.5.5 Septodont Recent Developments/Updates
6.6 Roche
6.6.1 Roche Company Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roche Pets NSAIDs Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 PerioChip
6.7.1 PerioChip Company Information
6.7.2 PerioChip Description and Business Overview
6.7.3 PerioChip Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PerioChip Pets NSAIDs Product Portfolio
6.7.5 PerioChip Recent Developments/Updates
6.8 Mobic
6.8.1 Mobic Company Information
6.8.2 Mobic Description and Business Overview
6.8.3 Mobic Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mobic Pets NSAIDs Product Portfolio
6.8.5 Mobic Recent Developments/Updates
6.9 Rimadyl
6.9.1 Rimadyl Company Information
6.9.2 Rimadyl Description and Business Overview
6.9.3 Rimadyl Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Rimadyl Pets NSAIDs Product Portfolio
6.9.5 Rimadyl Recent Developments/Updates
6.10 Vetprofen
6.10.1 Vetprofen Company Information
6.10.2 Vetprofen Description and Business Overview
6.10.3 Vetprofen Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vetprofen Pets NSAIDs Product Portfolio
6.10.5 Vetprofen Recent Developments/Updates
6.11 Novox
6.11.1 Novox Company Information
6.11.2 Novox Description and Business Overview
6.11.3 Novox Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novox Pets NSAIDs Product Portfolio
6.11.5 Novox Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pets NSAIDs Industry Chain Analysis
7.2 Pets NSAIDs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pets NSAIDs Production Mode & Process Analysis
7.4 Pets NSAIDs Sales and Marketing
7.4.1 Pets NSAIDs Sales Channels
7.4.2 Pets NSAIDs Distributors
7.5 Pets NSAIDs Customer Analysis
8 Pets NSAIDs Market Dynamics
8.1 Pets NSAIDs Industry Trends
8.2 Pets NSAIDs Market Drivers
8.3 Pets NSAIDs Market Challenges
8.4 Pets NSAIDs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pets NSAIDs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pets NSAIDs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pets NSAIDs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pets NSAIDs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pets NSAIDs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pets NSAIDs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pets NSAIDs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pets NSAIDs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pets NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pets NSAIDs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pets NSAIDs, Product Type & Application
 Table 12. Global Key Manufacturers of Pets NSAIDs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pets NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets NSAIDs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pets NSAIDs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pets NSAIDs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pets NSAIDs Sales Market Share by Region (2020-2025)
 Table 19. Global Pets NSAIDs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pets NSAIDs Sales Market Share by Region (2026-2031)
 Table 21. Global Pets NSAIDs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pets NSAIDs Revenue Market Share by Region (2020-2025)
 Table 23. Global Pets NSAIDs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pets NSAIDs Revenue Market Share by Region (2026-2031)
 Table 25. North America Pets NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pets NSAIDs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pets NSAIDs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pets NSAIDs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pets NSAIDs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pets NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pets NSAIDs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pets NSAIDs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pets NSAIDs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pets NSAIDs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pets NSAIDs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pets NSAIDs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pets NSAIDs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pets NSAIDs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pets NSAIDs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pets NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pets NSAIDs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pets NSAIDs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pets NSAIDs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pets NSAIDs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pets NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pets NSAIDs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pets NSAIDs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pets NSAIDs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pets NSAIDs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pets NSAIDs Sales (K Units) by Type (2020-2025)
 Table 51. Global Pets NSAIDs Sales (K Units) by Type (2026-2031)
 Table 52. Global Pets NSAIDs Sales Market Share by Type (2020-2025)
 Table 53. Global Pets NSAIDs Sales Market Share by Type (2026-2031)
 Table 54. Global Pets NSAIDs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pets NSAIDs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pets NSAIDs Revenue Market Share by Type (2020-2025)
 Table 57. Global Pets NSAIDs Revenue Market Share by Type (2026-2031)
 Table 58. Global Pets NSAIDs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pets NSAIDs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pets NSAIDs Sales (K Units) by Application (2020-2025)
 Table 61. Global Pets NSAIDs Sales (K Units) by Application (2026-2031)
 Table 62. Global Pets NSAIDs Sales Market Share by Application (2020-2025)
 Table 63. Global Pets NSAIDs Sales Market Share by Application (2026-2031)
 Table 64. Global Pets NSAIDs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pets NSAIDs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pets NSAIDs Revenue Market Share by Application (2020-2025)
 Table 67. Global Pets NSAIDs Revenue Market Share by Application (2026-2031)
 Table 68. Global Pets NSAIDs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pets NSAIDs Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Pets NSAIDs Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bayer Pets NSAIDs Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. JandJ Company Information
 Table 81. JandJ Description and Business Overview
 Table 82. JandJ Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. JandJ Pets NSAIDs Product
 Table 84. JandJ Recent Developments/Updates
 Table 85. GSK Company Information
 Table 86. GSK Description and Business Overview
 Table 87. GSK Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. GSK Pets NSAIDs Product
 Table 89. GSK Recent Developments/Updates
 Table 90. Septodont Company Information
 Table 91. Septodont Description and Business Overview
 Table 92. Septodont Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Septodont Pets NSAIDs Product
 Table 94. Septodont Recent Developments/Updates
 Table 95. Roche Company Information
 Table 96. Roche Description and Business Overview
 Table 97. Roche Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Roche Pets NSAIDs Product
 Table 99. Roche Recent Developments/Updates
 Table 100. PerioChip Company Information
 Table 101. PerioChip Description and Business Overview
 Table 102. PerioChip Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. PerioChip Pets NSAIDs Product
 Table 104. PerioChip Recent Developments/Updates
 Table 105. Mobic Company Information
 Table 106. Mobic Description and Business Overview
 Table 107. Mobic Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Mobic Pets NSAIDs Product
 Table 109. Mobic Recent Developments/Updates
 Table 110. Rimadyl Company Information
 Table 111. Rimadyl Description and Business Overview
 Table 112. Rimadyl Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Rimadyl Pets NSAIDs Product
 Table 114. Rimadyl Recent Developments/Updates
 Table 115. Vetprofen Company Information
 Table 116. Vetprofen Description and Business Overview
 Table 117. Vetprofen Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Vetprofen Pets NSAIDs Product
 Table 119. Vetprofen Recent Developments/Updates
 Table 120. Novox Company Information
 Table 121. Novox Description and Business Overview
 Table 122. Novox Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Novox Pets NSAIDs Product
 Table 124. Novox Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Pets NSAIDs Distributors List
 Table 128. Pets NSAIDs Customers List
 Table 129. Pets NSAIDs Market Trends
 Table 130. Pets NSAIDs Market Drivers
 Table 131. Pets NSAIDs Market Challenges
 Table 132. Pets NSAIDs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pets NSAIDs
 Figure 2. Global Pets NSAIDs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pets NSAIDs Market Share by Type: 2024 & 2031
 Figure 4. Injection Type Product Picture
 Figure 5. Oral Type Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Pets NSAIDs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pets NSAIDs Market Share by Application: 2024 & 2031
 Figure 9. Pet Hospital
 Figure 10. Pet Shop
 Figure 11. Household Use
 Figure 12. Global Pets NSAIDs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pets NSAIDs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Pets NSAIDs Sales (2020-2031) & (K Units)
 Figure 15. Global Pets NSAIDs Average Price (US$/Unit) & (2020-2031)
 Figure 16. Pets NSAIDs Report Years Considered
 Figure 17. Pets NSAIDs Sales Share by Manufacturers in 2024
 Figure 18. Global Pets NSAIDs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Pets NSAIDs Players: Market Share by Revenue in Pets NSAIDs in 2024
 Figure 20. Pets NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Pets NSAIDs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Pets NSAIDs Sales Market Share by Country (2020-2031)
 Figure 23. North America Pets NSAIDs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Pets NSAIDs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Pets NSAIDs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pets NSAIDs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pets NSAIDs Revenue Market Share by Region (2020-2031)
 Figure 35. China Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Pets NSAIDs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Pets NSAIDs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Pets NSAIDs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Pets NSAIDs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Pets NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Pets NSAIDs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Pets NSAIDs by Type (2020-2031)
 Figure 56. Global Pets NSAIDs Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Pets NSAIDs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Pets NSAIDs by Application (2020-2031)
 Figure 59. Global Pets NSAIDs Price (US$/Unit) by Application (2020-2031)
 Figure 60. Pets NSAIDs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure